Scarica l'app Stockscreener
231.54
0.78%
-1.83
Dopo l'orario di chiusura:
231.50
-0.04
-0.02%
Penumbra Inc Borsa (PEN) Ultime notizie
Is Penumbra Inc. stock undervalued vs historical averages2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Why Penumbra Inc. stock fits value portfolios2025 Stock Rankings & High Yield Equity Trading Tips - newser.com
Is Penumbra Inc. stock a contrarian opportunityPortfolio Growth Summary & Community Supported Trade Ideas - newser.com
Is Penumbra Inc. stock a top hedge fund pickLong Setup & Weekly Return Optimization Plans - newser.com
Is Penumbra Inc. (0P8) stock a momentum leaderJuly 2025 Technicals & Low Risk Entry Point Guides - newser.com
Is Penumbra’s Stock Still a Good Bet After a 7% Drop in the Past Month? - Yahoo Finance
Custom watchlist performance reports with Penumbra Inc.Entry Point & Verified Short-Term Plans - newser.com
Ischemic Neurological Interventional Medical Devices Market - openPR.com
Penumbra Enters Oversold Territory (PEN) - Nasdaq
Why Penumbra (PEN) Shares Are Falling Today - Yahoo Finance
Truist Financial Sticks to Its Buy Rating for Penumbra (PEN) - The Globe and Mail
How strong dollar benefits Penumbra Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
Does Penumbra Inc. stock trade at a discount to peersMarket Growth Review & Free Reliable Trade Execution Plans - newser.com
Is Penumbra Inc. (0P8) stock a buy for dividend portfoliosPortfolio Gains Summary & High Accuracy Trade Signal Alerts - newser.com
Why Penumbra Inc. stock is a strong buy callJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism - Lelezard
Will Penumbra Inc. stock attract ESG investorsJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Penumbra takes TCT by STORM - BioWorld MedTech
Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights - TipRanks
Is Penumbra Inc. (0P8) stock among top earnings playsJuly 2025 Update & Reliable Entry Point Trade Alerts - Fundação Cultural do Pará
Penumbra Inc.’s STRIKE-PE Study: A Game Changer for Pulmonary Embolism Treatment? - TipRanks
Penumbra, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape - Markets Mojo
Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors - TipRanks
Penumbra Inc.’s BOLT Study: A Game-Changer for Deep Vein Thrombosis Treatment? - TipRanks
Penumbra study backs mechanical thrombectomy for treating pulmonary embolism - MassDevice
Penumbra (PEN) Trial Shows Superior Results with Mechanical Thro - GuruFocus
Penumbra’s thrombectomy system shows superior results for PE patients - Investing.com
Penumbra’s thrombectomy system shows superior results for PE patients By Investing.com - Investing.com Nigeria
Penumbra (NYSE: PEN) RCT: CAVT 78.3% positive effect vs 51.9% with anticoagulation - Stock Titan
Deep Dive Into Penumbra Stock: Analyst Perspectives (13 Ratings) - Benzinga
Penumbra (PEN) Maintains Buy Rating with $326 Price Target by Ne - GuruFocus
PEN: BTIG Reiterates Buy Rating with $320 Price Target | PEN Sto - GuruFocus
Why Penumbra Inc. (0P8) stock is a strong buy callWeekly Stock Report & Consistent Return Investment Signals - newser.com
1.33%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):